Sign In  |  Register  |  About San Anselmo  |  Contact Us

San Anselmo, CA
September 01, 2020 1:33pm
7-Day Forecast | Traffic

  • Search Hotels in San Anselmo

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about MKGAF

Recent news which mentions MKGAF

Merck Germany's Two Pivotal Trials Flunk In Multiple Sclerosis
Tickers MKGAF MKKGY SNY
Tags Expert Ideas Briefs News
From Benzinga
Life Sciences Player Repligen's Strategic European Acquisition - What It Means for Investors
Tickers MKGAF MKKGY RGEN
Tags Health Care Analyst Ratings Market News
From Benzinga
Merck Germany Reports 5% Decline In Q2 Sales, Expects More Decline In 2023
Tickers MKGAF MKKGY
Tags Briefs News Earnings
From Benzinga
Novo Nordisk's Obesity Drug Saxenda Not Included In WHO's Essential Drug List
Tickers MKGAF MKKGY NVO REGN
Tags MKKGY Government General
From Benzinga
Abcam Downgrade: Analyst Trims Expectations Amid Activist Investor Engagement and Potential Bid Anticipation
Tickers A ABCM DHR MKGAF
Tags TECH Downgrades Expert Ideas
From Benzinga
Roche's Investigational Drug For Relapsing Multiple Sclerosis Reduces Brain Lesions, Data Shows
Tickers MKGAF RHHBF RHHBY RHHVF
Tags Biotech Health Care Market News
From Benzinga
Analyst Says Nektar Therapeutics' Rezpeg Prioritization Likely to Spark Investor Questions
Tickers LLY MKGAF MKKGY NKTR
Tags Market News Analyst Ratings LLY
From Benzinga
FDA Issues Partial Clinical Hold On Merck Germany's Multiple Sclerosis Study
Tickers MKGAF MKKGY
Tags News Briefs General
From Benzinga
Merck Germany Regains Exclusive Global Rights To Cancer Drug From Pfizer
Tickers M MKGAF MKKGY PFE
Tags Large Cap Biotech Contracts
From Benzinga
Incyte Would Now Compete With Merck, Pfizer As Its Skin Cancer Treatment Scores FDA Accelerated Approval
Tickers INCY MGNX MKGAF MKKGY
Tags Benzinga MKGAF FDA
From Benzinga
PDS Biotech, Merck Germany Enter Licensing Pact For Investigational Cancer Treatment
Tickers MKGAF MKKGY PDSB
Tags PDSB Briefs News
From Benzinga
Mersana Inks Cancer Therapy Development Deal With Merck Germany
Tickers MKGAF MKKGY MRSN
Tags General MKKGY Briefs
From Benzinga
GlaxoSmithKline, Merck KGaA End $4B Cancer Drug Pact
Tickers GSK MKGAF MKKGY MRK
Tags MKKGY General lung cancer
From Benzinga
Nektar, Merck Germany, Pfizer Join Forces For Mid-Stage Bladder Cancer Study
Tickers MKGAF MKKGY NKTR PFE
Tags Health Care NKTR Biotech
From Benzinga
Merck KGaA Pulls Plug On GSK-Partnered Cancer Drug Trial
Tickers GSK MKGAF MKKGY MRK
Tags Biotech oncology Health Care
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 SanAnselmo.com & California Media Partners, LLC. All rights reserved.